thrombin receptor peptide sfllrnp has been researched along with Purpura, Thrombocytopenic, Idiopathic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berny-Lang, MA; Brown, T; Carmichael, SL; Frelinger, AL; Gerrits, AJ; Grace, RF; Michelson, AD; Neufeld, EJ | 1 |
| Babula, B; Barnard, MR; Bussel, JB; Frelinger, AL; Li, Y; Linden, MD; Mathur, K; Michelson, AD; Psaila, B; Tate, C | 1 |
2 other study(ies) available for thrombin receptor peptide sfllrnp and Purpura, Thrombocytopenic, Idiopathic
| Article | Year |
|---|---|
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.
Topics: Adolescent; Blood Platelets; Cell Differentiation; Cell-Derived Microparticles; Child; Child, Preschool; Cross-Sectional Studies; Female; Flow Cytometry; Hemorrhage; Humans; Light; Male; Mean Platelet Volume; P-Selectin; Peptide Fragments; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Receptor, PAR-1; Scattering, Radiation | 2015 |
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.
Topics: Adult; Aged; Aged, 80 and over; Benzoates; Blood Platelets; Case-Control Studies; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Female; Flow Cytometry; Humans; Hydrazines; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Randomized Controlled Trials as Topic | 2012 |